Skip Nav Destination
Issues
1 June 2017
-
Cover Image
Cover Image
About the CoverClose Modal
This issue of Cancer Immunology Research includes a Cancer Immunology at the Crossroads article that highlights two of the many ways in which tumors can evade immune surveilliance. Both of these “tricks” employ the repurposing of how two elements, oxygen and potassium, engage with the tumor microenvironment and the resultant suppression of antitumor immune responses. Read more in Gurusamy et al., beginning on page 426. The original image is of a resected metastatic colon tumor stained with hematoxylin and eosin. Photo from the Restifo laboratory. Artwork by Lewis Long. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 2326-6066
EISSN 2326-6074
Journal Archive
Cancer Immunology Research (2013-Present)
(ISSN 2326-6066) Published monthly since 2013.Cancer Immunity (2001-2013; volumes 1-13)
(EISSN 1424-9634) Published periodically from 2001-2013.Table of Contents
Highlights from the Literature
Cancer Immunology at the Crossroads
Meeting Report
Cancer Immunology Miniatures
4-1BB–Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells
Michiko Harao; Marie-Andrée Forget; Jason Roszik; Hui Gao; Gildy V. Babiera; Savitri Krishnamurthy; Jessica A. Chacon; Shumin Li; Elizabeth A. Mittendorf; Sarah M. DeSnyder; Korrene F. Rockwood; Chantale Bernatchez; Naoto T. Ueno; Laszlo G. Radvanyi; Luis Vence; Cara Haymaker; James M. Reuben
Research Articles
Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Xinqi Wu; Jingjing Li; Erin M. Connolly; Xiaoyun Liao; Jing Ouyang; Anita Giobbie-Hurder; Donald Lawrence; David McDermott; George Murphy; Jun Zhou; Matthias Piesche; Glenn Dranoff; Scott Rodig; Margaret Shipp; F. Stephen Hodi
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Christina Engel; Grethe Brügmann; Silke Lambing; Larissa H. Mühlenbeck; Samira Marx; Christian Hagen; Dorottya Horváth; Marion Goldeck; Janos Ludwig; Anna-Maria Herzner; Jan W. Drijfhout; Daniela Wenzel; Christoph Coch; Thomas Tüting; Martin Schlee; Veit Hornung; Gunther Hartmann; Jasper G. Van den Boorn
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Jeremy B. Foote; Marleen Kok; James M. Leatherman; Todd D. Armstrong; Bridget C. Marcinkowski; Laureen S. Ojalvo; David B. Kanne; Elizabeth M. Jaffee; Thomas W. Dubensky, Jr; Leisha A. Emens
Author Choice
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Jun Zhou; Kathleen M. Mahoney; Anita Giobbie-Hurder; Fengmin Zhao; Sandra Lee; Xiaoyun Liao; Scott Rodig; Jingjing Li; Xinqi Wu; Lisa H. Butterfield; Matthias Piesche; Michael P. Manos; Lauren M. Eastman; Glenn Dranoff; Gordon J. Freeman; F. Stephen Hodi
Advertisement